COST-EFFECTIVENESS ANALYSIS OF THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (ALTEPLASE) FOR ACUTE ISCHEMIC STROKE UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

被引：0
|
作者：
Teich, V [1 ]
Passos, R. B. F. [1 ]
Vianna, D. [2 ]
机构：
[1] MedInsight, Rio De Janeiro, Brazil
[2] Univ Rio de Janeiro, Rio De Janeiro, Brazil
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75381-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A503 / A503
页数：1
相关论文
共 50 条
  • [1] PROJECTED COST SAVINGS ASSOCIATED WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR THROMBOLYSIS AFTER ACUTE ISCHEMIC STROKE FROM THE MEXICAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
    Cardona, D. P.
    Burbano-Levy, X.
    Palacios, E.
    Diez-Canseco, F.
    Herran, S.
    Zapata, L.
    VALUE IN HEALTH, 2014, 17 (03) : A113 - A113
  • [2] Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
    Fagan, SC
    Morgenstern, LB
    Petitta, A
    Ward, RE
    Tilley, BC
    Marler, JR
    Levine, SR
    Broderick, JP
    Kwiatkowski, TG
    Frankel, M
    Brott, TG
    Walker, MD
    NEUROLOGY, 1998, 50 (04) : 883 - 890
  • [3] Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
    Riggs, JE
    NEUROLOGY, 1999, 52 (04) : 895 - 895
  • [4] Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UKNHS costs
    Sandercock, P
    Berge, E
    Dennis, M
    Forbes, J
    Hand, P
    Kwan, J
    Lewis, S
    Lindley, R
    Neilson, A
    Wardlaw, J
    STROKE, 2004, 35 (06) : 1490 - 1497
  • [5] Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran
    Amiri, Asrin
    Goudarzi, Reza
    Amiresmaili, Mohammadreza
    Iranmanesh, Farhad
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (03) : 282 - 287
  • [6] Cost-Effectiveness of Recombinant Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke: A Systematic Review
    Jung, Kee-Taig
    Shin, Dong Wook
    Lee, Kyung-Jin
    Oh, Myungju
    JOURNAL OF CLINICAL NEUROLOGY, 2010, 6 (03): : 117 - 126
  • [7] Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a Chilean public hospital
    Figueroa-Reyes, Tatiana
    Saez M, David
    Mansilla L, Eloy
    Sanchez, Rodrigo, V
    Nogales-Gaete, Jorge
    Delgado B, Iris
    REVISTA MEDICA DE CHILE, 2011, 139 (09) : 1118 - 1127
  • [8] A Literature Review of Cost-effectiveness of Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke
    Wang Guijing
    Joo, Heesoo
    George, Mary G.
    STROKE, 2016, 47
  • [9] COST-EFFECTIVENESS OF THROMBOLYSIS WITH ALTEPLASE IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN SLOVAKIA
    Blazinska, L.
    Psota, M.
    Spitzerova, H.
    Psenkova, M.
    VALUE IN HEALTH, 2019, 22 : S596 - S596
  • [10] TENECTEPLASE OR ALTEPLASE FOR ACUTE ISCHEMIC STROKE? A COST-EFFECTIVENESS ANALYSIS
    Nguyen, C.
    Lahr, M. M. H.
    Van der Zee, D. J.
    Van Voorst, H.
    Roos, Y. B. W. E. M.
    Uyttenboogaart, M.
    Buskens, E.
    VALUE IN HEALTH, 2022, 25 (12) : S167 - S167
12345